Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Long-Term Debt Repayments (2024 - 2026)

Cannabis Bioscience International Holdings filings provide 3 years of Long-Term Debt Repayments readings, the most recent being -$84627.0 for Q1 2026.

  • On a quarterly basis, Long-Term Debt Repayments rose 17.64% to -$84627.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$90992.0, a N/A change, with the full-year FY2024 number at $19000.0, changed N/A from a year prior.
  • Long-Term Debt Repayments reached -$84627.0 in Q1 2026 per CBIH's latest filing, down from $5402.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $90983.0 in Q3 2025, with the low at -$102750.0 in Q1 2025.
  • A 3-year average of $4035.0 and a median of $16487.0 in 2024 define the central range for Long-Term Debt Repayments.
  • Peak annual rise in Long-Term Debt Repayments hit 197.07% in 2025, while the deepest fall reached 723.22% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $72123.0 in 2024, then tumbled by 92.51% to $5402.0 in 2025, then crashed by 1666.59% to -$84627.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Long-Term Debt Repayments are -$84627.0 (Q1 2026), $5402.0 (Q4 2025), and $90983.0 (Q3 2025).